For citations:
Rumyantsev A.A., Protasova A.E., Sheremet M.Yu., Goryainova A.Yu., Volkonskiy M.V., Kedrova A.G., Kuzmicheva S.V., Aymamedova O.N., Musaeva Kh.S., Soroka S.M., Romanchuk O.V., Orlova V.N., Graft N.G., Ibragimova M.R., Merzlikina Yu.I., Stepura L.V., Tatulova L.B., Abasova A.A., Akopyan A.A., Arsenyeva E.V., Vasilyeva Yu.V., Belonogov A.V., Krivolapova L.V., Bobryshev A.A., Vovk D.Yu., Luev I.A., Abidova N.R., Zhikhorev R.S., Zhelezkova T.A., Grigoryan T.T., Makarkina T.A., Ekimov V.A., Zhizhina A.V., Karabina E.V., Kuchevskaya O.A., Filippova V.M., Linchenko T.A., Lisaeva A.A., Fedorova A.N., Maystrenko K.S., Markizova E.V., Kogay E.V., Krasnorutskaya E.P., Popova M.E., Pchelin Yu.Yu., Ryanzhina R.A., Sidorov D.B., Shakhnovich E.B., Alekseev S.M., Zinkevich M.V., Belogortsev I.O., Chubenko V.A., Moiseenko V.M., Abduloeva N.Kh., Lebedinets A.A., Strakh L.V., Semenov L.K., Bolieva M.B., Aydaeva F.Z. Efficacy and safety of lenvatinib and pembrolizumab in the treatment of endometrial cancer: data from routine clinical practice in Russia. Tumors of female reproductive system. 2023;19(4):104-113. (In Russ.) https://doi.org/10.17650/1994-4098-2023-19-4-104-113
Email this article 